ОбзорГрафикНовостиTraderScreen

DZ Bank Call 2.8488 MDG2 20.06.20.../  DE000DJ5F4M6  /

EUWAX
13.11.2024  9:45:18 Изменение0.000 Бид22:00:32 Предложение22:00:32 Базовый актив Цена исполнения Дата истечения Тип опциона
0.010EUR 0.00% -
Величина цены спроса: -		 -
Величина цены предложения: -		 MEDIGENE AG NA O.N. 2.8488 EUR 20.06.2025 Call
GlobeNewswire 29.08 Medigene AG Secures Two Additional Patents for Technologies in Its End-to-End Platform
GlobeNewswire 28.08 Medigene to Present at Upcoming Investor Conferences
GlobeNewswire 26.08 Medigene AG implements announced 2:1 share capital reduction and consolidation of the shares effecti...
GlobeNewswire 14.08 Medigene AG Reports Half-Year 2024 Financial Results and Provides Corporate Update
GlobeNewswire 08.08 Medigene AG to Report Half-Year 2024 Financial Results on August 14, 2024
GlobeNewswire 08.08 Medigene and WuXi Biologics Enter into a Research Collaboration for Off-the-Shelf TCR-Guided T Cell ...
GlobeNewswire 23.07 Medigene to Present at ESMO Congress 2024
GlobeNewswire 03.07 Medigene AG Expands Patent Portfolio with the Patent Grant for its NY-ESO-1/LAGE 1a Targeted T Cell ...
GlobeNewswire 27.06 Medigene Presents Efficient 6-Day TCR-T Therapy Production Process with High Stemness
GlobeNewswire 24.06 Medigene Reports Results of Annual General Meeting
GlobeNewswire 21.06 Medigene to Present at the Cell and Gene Therapy In-Depth Focus Summit 2024
GlobeNewswire 20.06 Medigene AG Announces Lead Selection for MDG2021, Expanding TCR-T KRAS Library Targeting Solid Tumor...
GlobeNewswire 11.06 Thermosome Appoints Dr. Sabine Hauck as Chief Technical Officer
GlobeNewswire 28.05 Medigene AG Expands its End-to-End Platform by Submitting Three Development Optimization Technology ...
GlobeNewswire 21.05 Medigene's Global Research & Collaboration Agreement with BioNTech to Extend Beyond Initially Announ...
GlobeNewswire 15.05 Medigene Presents Preclinical Data on Optimal Affinity TCRs Targeting the Neoantigen Mutant KRAS
GlobeNewswire 14.05 Medigene AG Extends Cash Runway into July 2025 After Successful Oversubscribed Capital Raise
GlobeNewswire 07.05 Medigene to Present at Upcoming Conferences
GlobeNewswire 06.05 The Benchmark Company Announces Upcoming Healthcare House Call VIRTUAL One-on-One Investor Conferenc...
GlobeNewswire 02.05 Medigene AG Expands Patent Portfolio with European Patent Grant for its NY-ESO-1 – targeted T Cell R...
GlobeNewswire 02.05 Medigene Presents Superior TCR-T Cell Functionality by Inclusion of a Costimulatory Switch Protein
GlobeNewswire 26.04 Medigene AG reports Financial Results and Business Update for Q1 2024
GlobeNewswire 25.04 Medigene presents streamlined 6-day, high stemness TCR-T therapy production process
GlobeNewswire 17.04 Medigene to Present at Upcoming Scientific Conferences
GlobeNewswire 08.04 Medigene Presents Favorable Safety Profile of TCR-T Cells with Costimulatory Switch Protein at AACR ...